ATE551355T1 - Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis - Google Patents

Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis

Info

Publication number
ATE551355T1
ATE551355T1 AT08170016T AT08170016T ATE551355T1 AT E551355 T1 ATE551355 T1 AT E551355T1 AT 08170016 T AT08170016 T AT 08170016T AT 08170016 T AT08170016 T AT 08170016T AT E551355 T1 ATE551355 T1 AT E551355T1
Authority
AT
Austria
Prior art keywords
ehrlichia
compositions
methods
detecting antibodies
canis
Prior art date
Application number
AT08170016T
Other languages
English (en)
Inventor
Robert Lawton
Thomas Patrick O'connor
Barbara Ann Bartol
Paul Scott Machenry
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of ATE551355T1 publication Critical patent/ATE551355T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/29Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT08170016T 2001-01-18 2002-01-16 Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis ATE551355T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/765,739 US7087372B2 (en) 2001-01-18 2001-01-18 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies

Publications (1)

Publication Number Publication Date
ATE551355T1 true ATE551355T1 (de) 2012-04-15

Family

ID=25074352

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08170016T ATE551355T1 (de) 2001-01-18 2002-01-16 Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis
AT02720810T ATE426172T1 (de) 2001-01-18 2002-01-16 Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis- antikírpern

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02720810T ATE426172T1 (de) 2001-01-18 2002-01-16 Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis- antikírpern

Country Status (9)

Country Link
US (5) US7087372B2 (de)
EP (2) EP2056112B1 (de)
JP (2) JP4384851B2 (de)
AT (2) ATE551355T1 (de)
AU (1) AU2002251784B2 (de)
CA (1) CA2433394C (de)
DE (1) DE60231607D1 (de)
ES (1) ES2324401T3 (de)
WO (1) WO2002057794A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
WO2006107924A2 (en) * 2005-04-04 2006-10-12 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infected from vaccinated animals)
EP2203469A4 (de) * 2007-09-21 2011-08-24 Idexx Lab Inc Verfahren und zusammensetzungen zum nachweis von ehrlichia chaffeensis (p120)
WO2009039414A2 (en) * 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (vlpt)
US20100222289A1 (en) * 2007-10-22 2010-09-02 Cfs Research Llc Methods for diagnosis and treatment of chronic fatigue syndrome
EP2664344B1 (de) * 2007-10-31 2019-02-27 Idexx Laboratories, Inc. Ehrlichia canis-diva (unterscheidung von infizierten und geimpften tieren)
AU2010321790B2 (en) * 2009-11-20 2016-08-04 Zoetis Services Llc Peptides, devices, and methods for the detection of Ehrlichia antibodies
US9651546B2 (en) 2012-10-11 2017-05-16 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
WO2019060695A1 (en) * 2017-09-22 2019-03-28 Kite Pharma, Inc. CHIMERIC POLYPEPTIDES AND USES THEREOF
WO2019199887A1 (en) * 2018-04-09 2019-10-17 Kansas State University Research Foundation Biosynthetic activity of the anaplasma phagocytophilum and ehrlichia chaffeensis phagosome in a host cell-free medium
US11046734B2 (en) 2018-07-27 2021-06-29 Research Development Foundation Chimeric immunogenic polypeptides
EP3738970A3 (de) * 2019-05-16 2021-02-17 The Trustees of Columbia University in the City of New York Serologischer test zum nachweis der exposition gegenüber und der infektion mit durch zecken übertragene erreger
CN117452342B (zh) * 2023-12-26 2024-03-19 湖南力研光电科技有限公司 一种基于极化特征的箔条干扰检测方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4676980A (en) * 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5192679A (en) 1990-05-03 1993-03-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Growing ehrlichia species in a continuous cell line
US5401656A (en) 1990-05-03 1995-03-28 United States Of America Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis
DE4100527C2 (de) * 1991-01-10 2001-11-29 Bosch Gmbh Robert Verfahren und Vorrichtung zum Bestimmen von Aussetzern in einer Brennkraftmaschine
AU1970892A (en) 1991-04-18 1992-11-17 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
FR2723950B1 (fr) 1994-08-24 1996-10-25 Bio Merieux Fragments nucleotidiques capables de s'hybrider specifiquemennt a l'adnr ou arnr des rickettsia et leur utilisation comme sondes ou amorces.
CA2160423A1 (en) 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
EP0839229A4 (de) * 1995-04-13 1999-09-22 Peter John Meldrum Ausgleichselement für formsteine
US5976860A (en) 1995-06-06 1999-11-02 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US6284238B1 (en) 1995-06-06 2001-09-04 Aquila Biopharmaceuticals, Inc. Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
US5928879A (en) 1995-08-25 1999-07-27 The Regents Of The University Of Minnesota Method of diagnosing human granulocytic Ehrlichiosis
US5869335A (en) 1995-08-25 1999-02-09 Regents Of The University Of Minnesota Method of growing rickettsiae in Ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae
US5955359A (en) 1995-08-25 1999-09-21 University Of Maryland At Baltimore Method of growing granulocytic ehrlichiae of the Ehrlichia phagocytophila genogroup in promyelocytic leukemia cell culture, and preparing antigens and vaccines of said granulocytic ehrlichiae
US6015691A (en) 1996-05-31 2000-01-18 Research Development Foundation Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis
US6653128B2 (en) 1996-10-17 2003-11-25 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
US6593147B1 (en) 1996-10-17 2003-07-15 University Of Florida Research Foundation, Inc. Nucleic acid vaccines against rickettsial diseases and methods of use
US6025338A (en) 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
US6207169B1 (en) 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US20020086984A1 (en) 1997-03-21 2002-07-04 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6231869B1 (en) 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
US20020068343A1 (en) 1997-03-21 2002-06-06 Reed Steven G. Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6277381B1 (en) 1997-03-21 2001-08-21 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
US6306394B1 (en) 1997-04-25 2001-10-23 Aquila Biopharmaceuticals Inc. Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
EP0915980B1 (de) 1997-04-25 2009-08-05 Antigenics Inc. Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
CA2304256C (en) 1997-09-19 2014-12-09 Yasuko Rikihisa Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis
US6544517B1 (en) 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en) 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US20020115840A1 (en) 1998-11-30 2002-08-22 Walker David H. Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof
US6458942B1 (en) 1998-11-30 2002-10-01 Research Development Foundation 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
US6355777B1 (en) 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
AU2001259304A1 (en) 2000-05-01 2001-11-12 Research Development Foundation Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
AU2001270222A1 (en) 2000-06-27 2002-01-08 Ubs Ag Method and system for providing distributed functionality and data analysis system utilizing same
US7183060B2 (en) 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
ITRM20010445A1 (it) 2001-07-25 2003-01-27 Sigma Tau Healthscience Spa Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
CA2612302C (en) 2005-06-16 2015-07-28 Research Development Foundation Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis

Also Published As

Publication number Publication date
US20030119082A1 (en) 2003-06-26
EP1386167B1 (de) 2009-03-18
EP1386167A2 (de) 2004-02-04
US7087372B2 (en) 2006-08-08
JP4384851B2 (ja) 2009-12-16
US20020160432A1 (en) 2002-10-31
WO2002057794A2 (en) 2002-07-25
AU2002251784B2 (en) 2006-09-14
EP2056112A1 (de) 2009-05-06
JP2009185037A (ja) 2009-08-20
US7445788B2 (en) 2008-11-04
DE60231607D1 (de) 2009-04-30
JP2005502586A (ja) 2005-01-27
EP2056112B1 (de) 2012-03-28
CA2433394C (en) 2013-09-10
ATE426172T1 (de) 2009-04-15
CA2433394A1 (en) 2002-07-25
WO2002057794A3 (en) 2003-11-20
US7449191B2 (en) 2008-11-11
US20070020733A1 (en) 2007-01-25
US20020177178A1 (en) 2002-11-28
ES2324401T3 (es) 2009-08-06
US20070026474A1 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
ATE551355T1 (de) Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis
ATE554107T1 (de) Als therapeutika geeignete monovalente antikörperfragmente
CY1116632T1 (el) Εξουδετερωτες αντισωματων του τελεστη διεγερσης αποικιων κοκκιοκυτταρων μακροφαγων ανθρωπου
DE60334645D1 (de) Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
CY2019022I2 (el) Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους
NO20054836L (no) Nogo-reseptorbindingsprotein
CY1117124T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
CY1108691T1 (el) Πολυπεπτιδια
DE602006013029D1 (de) Anti-egfr-antikörper
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
CY1110923T1 (el) Συζυγη που περιλαμβανουν ενα αντισωμα ειδικο για την ed-β περιοχη της ινονεκτινης και η χρηση τους για τον εντοπισμο και την αντιμετωπιση ογκων
DK1406656T3 (da) Fremgangsmåder til administrering af anti-TNF-alfa-antistoffer
DE60300734D1 (de) Anordnungen zur Vorbehandlung von Proben
DE502005009389D1 (de) Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
DE60306920D1 (de) Vorrichtung zur bestimmung der feinheit von mineralfasern
EP1832601A3 (de) Zusammensetzungen und Verfahren für den Nachweis von Ehrlichia Canis- und Ehrlichia Chaffeensis-Antikörpern
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
DK1875237T3 (da) Docetaxel-immunassay
ATE498134T1 (de) Nachweis von staphylococcus
DE60321041D1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
DE602004024921D1 (de) Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs
ATE539746T1 (de) Zusammensetzung zur verbesserung von kognition und gedächtnis
DE602004023199D1 (de) Fluoreszenzprotein und pigmentprotein
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE602004016906D1 (de) Reagenz zum Nachweis von anti-Phospholipid Antikörper